agilon health, inc. (NYSE:AGL) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. cut its position in shares of agilon health, inc. (NYSE:AGL) by 30.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,894 shares of the company’s stock after selling 12,781 shares during the quarter. Principal Financial Group Inc.’s holdings in agilon health were worth $114,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. State Street Corp lifted its holdings in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after acquiring an additional 215,733 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after purchasing an additional 84,889 shares in the last quarter. Citigroup Inc. lifted its stake in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares during the period. Finally, Barclays PLC grew its stake in shares of agilon health by 21.2% in the third quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after buying an additional 214,830 shares in the last quarter.

agilon health Trading Up 4.9 %

Shares of NYSE AGL opened at $2.16 on Wednesday. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $9.30. The stock has a market cap of $889.96 million, a price-to-earnings ratio of -2.30 and a beta of 0.53. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company’s fifty day moving average is $2.08 and its 200-day moving average is $3.82.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the prior year, the company earned ($0.06) EPS. Equities research analysts predict that agilon health, inc. will post -0.52 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Sanford C. Bernstein initiated coverage on shares of agilon health in a research report on Wednesday, December 11th. They set a “market perform” rating and a $2.50 target price on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Macquarie initiated coverage on agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target on the stock. Finally, JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $3.95.

Insiders Place Their Bets

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of $2.20 per share, with a total value of $55,000.00. Following the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This represents a 51.90 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the stock in a transaction on Thursday, December 5th. The shares were bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the transaction, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 90,000 shares of company stock valued at $198,100 in the last quarter. 3.20% of the stock is currently owned by insiders.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.